Trade Loncar Cancer Immunotherapy ETF - CNCR CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.18 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023429% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001207% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 9.16 |
| Open | 9.28 |
| 1-Year Change | -34.09% |
| Day's Range | 9.27 - 9.61 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 21, 2025 | 9.16 | 0.31 | 3.50% | 8.85 | 9.33 | 8.85 |
| Apr 17, 2025 | 9.00 | 0.27 | 3.09% | 8.73 | 9.00 | 8.71 |
| Apr 16, 2025 | 8.75 | -0.12 | -1.35% | 8.87 | 8.90 | 8.61 |
| Apr 15, 2025 | 9.05 | 0.08 | 0.89% | 8.97 | 9.10 | 8.86 |
| Apr 14, 2025 | 8.97 | 0.07 | 0.79% | 8.90 | 8.97 | 8.67 |
| Apr 11, 2025 | 8.76 | 0.59 | 7.22% | 8.17 | 8.76 | 8.17 |
| Apr 10, 2025 | 8.22 | -0.03 | -0.36% | 8.25 | 8.32 | 7.91 |
| Apr 9, 2025 | 8.48 | 0.66 | 8.44% | 7.82 | 8.69 | 7.62 |
| Apr 8, 2025 | 7.89 | -0.54 | -6.41% | 8.43 | 8.54 | 7.82 |
| Apr 7, 2025 | 8.31 | 0.27 | 3.36% | 8.04 | 8.51 | 7.82 |
| Apr 4, 2025 | 8.38 | -0.10 | -1.18% | 8.48 | 8.59 | 8.23 |
| Apr 3, 2025 | 8.78 | 0.05 | 0.57% | 8.73 | 8.95 | 8.69 |
| Apr 2, 2025 | 9.18 | 0.26 | 2.91% | 8.92 | 9.24 | 8.86 |
| Apr 1, 2025 | 8.96 | -0.36 | -3.86% | 9.32 | 9.32 | 8.92 |
| Mar 31, 2025 | 9.34 | -0.20 | -2.10% | 9.54 | 9.54 | 9.23 |
| Mar 28, 2025 | 9.83 | -0.14 | -1.40% | 9.97 | 9.99 | 9.83 |
| Mar 27, 2025 | 10.03 | 0.06 | 0.60% | 9.97 | 10.06 | 9.97 |
| Mar 26, 2025 | 9.97 | -0.38 | -3.67% | 10.35 | 10.35 | 9.97 |
| Mar 25, 2025 | 10.36 | -0.30 | -2.81% | 10.66 | 10.68 | 10.36 |
| Mar 24, 2025 | 10.76 | 0.17 | 1.61% | 10.59 | 10.76 | 10.50 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Loncar Cancer Immunotherapy ETF Company profile
The investment seeks to track the total return performance, before fees and expenses, of the Loncar Cancer Immunotherapy Index. The index is composed of the common stock of approximately 30 pharmaceutical or biotechnology companies identified by the fund's index provider, as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. The adviser attempts to invest all, or substantially all, of its assets in the component securities and ADRs that make up the index. At least 80% of its total assets will be invested in the component securities of the index.News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com